The Effect of Superdisintegrants on the Dissolution of Promethazine. HCl Fast Dissolving Tablets
DOI:
https://doi.org/10.37285/ijpsn.2010.3.1.10Abstract
Promethazine.HCl is a potent anti-emetic. The central antimuscarinic actions of antihistamines are probably responsible for their anti-emetic effects. Promethazine is also believed to inhibit the medullary chemoreceptor trigger zone, and antagonize apomorphine -induced vomiting. Fast dissolving tablets of Promethazine.HCl were prepared using five superdisintegrants viz; sodium starch glycolate, crospovidone, croscarmellose, L-HPC and pregelatinised starch. The precompression blend was tested for angle of repose, bulk density, tapped density, compressibility index and Hausner’s ratio. The tablets were evaluated for weight variation, hardness, friability, disintegration time (1 min), dissolution rate, content uniformity, and were found to be within standard limit. It was concluded that the fast dissolving tablets with proper hardness, rapidly disintegrating with enhanced dissolution can be made using selected superdisintegrants. Among the different formulations of Promethazine.HCl was prepared and studied and the formulation S2 containing crospovidone, mannitol and microcrystalline cellulose combination was found to be the fast dissolving formulation. In the present study an attempt has been made to prepare fast dissolving tablets of Promethazine.HCl, by using different superdisintegrants with enhanced disintegration and dissolution rate.
Downloads
Metrics
Keywords:
Fast dissolving tablets, Promethazine.HCl, SuperdisintegrantDownloads
Published
How to Cite
Issue
Section
References
Abu-lazza, Khawla, A., Li, Vincent, H., Look, Jee, L., Parr, Grahm, D., Schineuer, and Matthew, K.; “Fast dissolving tablet”, US Patent 6733781, May 11, 2004.
Amin, A. F., Shah, T. J., Bhadani, M. N., and Patel, M. M.; “Emerging trends in the development of orally disintegrating tablet technology”, Jan-2006.
Blank, R. G., Mody, D. S., Kenny, R. J., and Avenson, M. C.; “Fast dissolving dosage form”, US Patent No. 4946684, Aug 7, 1990.
Dollery, C.; Therapeutic Drugs, Second edition, Churchill Livingstone, Vol I & II, 1999, aD196-D199, bF14-F18, cL9-L13, dL95-L98.
Lachman, L., Liberman, H. A., and Kanig, J. L.; “The Theory and Practice of Industrial Pharmacy”, Third edition, Varghese Publishing House, Bombay, 1987, 293-342.
Makino, T., Yamada, M., and Kikuta, J.; “Fast-Dissolving tablets and its production”, US Patent No. 5501861, Mar 26, 1996.
Mosby’s; The Complete Drug Reference, seventh Edition, II 443-48, II 1581-1586.
M.M.Patel and D.M.Patel, Indian Journal of Pharmaceuticals Sciences, March-April 2006, 222-226.
Sweetman, S. C.; Martindale, The Complete Drug Reference, Thirty third edition, Pharmaceutical Press, London, Chicago, 2002, 660-664, 1241-1244.
Vandana B Patravale and Namita B Prabhu, Indian Journal of Pharmaceutical Sciences,Mar-Apr 2005,233-235.
Yunxia, B., Hisakazu, Yurinobu, Y., Kazumi, D., Akinobu, O., and Kotaro, I.; “Preparation and evaluation of compressed tablet rapidly disintegrating in the oral cavity”, Chem. Pharm. Bull., 1996, 44(11), 2121-2127.
www.pharmainfo.net/exclusive/reviews/emerging_trends_in_the_development_of_orally_disintegrating_tablet_technology/